Literature DB >> 27293541

Osteoporosis in liver disease: pathogenesis and management.

Gabriela Handzlik-Orlik1, Michał Holecki2, Krzysztof Wilczyński2, Jan Duława2.   

Abstract

Osteoporosis affects a substantial proportion of patients with chronic liver disease. Pathologic fracture in osteoporosis significantly affects quality of life and life expectancy. By some estimates, 40% of patients with chronic liver disease may experience osteoporotic fracture. In this study we review the pathogenesis, diagnosis and treatment of specific liver disease entities and their relation to osteoporosis.

Entities:  

Keywords:  bone metabolism; cirrhosis; hemochromatosis; nonalcoholic fatty liver disease; osteoporosis

Year:  2016        PMID： 27293541      PMCID： PMC4892399          DOI： 10.1177/2042018816641351

Source DB:  PubMed          Journal:  Ther Adv Endocrinol Metab        ISSN： 2042-0188            Impact factor:   3.565


  50 in total

1.  Bone disease after liver transplantation: a long-term prospective study of bone mass changes, hormonal status and histomorphometric characteristics.

Authors:  A Monegal; M Navasa; N Guañabens; P Peris; F Pons; M J Martinez de Osaba; J Ordi; A Rimola; J Rodés; J Muñoz-Gómez
Journal:  Osteoporos Int       Date:  2001       Impact factor: 4.507

2.  Severity of cholestasis and advanced histological stage but not menopausal status are the major risk factors for osteoporosis in primary biliary cirrhosis.

Authors:  Núria Guañabens; Albert Parés; Inmaculada Ros; Llorenç Caballería; Francesca Pons; Sergi Vidal; Ana Monegal; Pilar Peris; Juan Rodés
Journal:  J Hepatol       Date:  2005-01-13       Impact factor: 25.083

3.  Practical guidelines for the supplementation of vitamin D and the treatment of deficits in Central Europe - recommended vitamin D intakes in the general population and groups at risk of vitamin D deficiency.

Authors:  Paweł Płudowski; Elżbieta Karczmarewicz; Milan Bayer; Graham Carter; Danuta Chlebna-Sokół; Justyna Czech-Kowalska; Romuald Dębski; Tamas Decsi; Anna Dobrzańska; Edward Franek; Piotr Głuszko; William B Grant; Michael F Holick; Liudmila Yankovskaya; Jerzy Konstantynowicz; Janusz B Książyk; Krystyna Księżopolska-Orłowska; Andrzej Lewiński; Mieczysław Litwin; Szimonetta Lohner; Roman S Lorenc; Jacek Lukaszkiewicz; Ewa Marcinowska-Suchowierska; Andrzej Milewicz; Waldemar Misiorowski; Michał Nowicki; Vladyslav Povoroznyuk; Piotr Rozentryt; Ema Rudenka; Yehuda Shoenfeld; Piotr Socha; Bogdan Solnica; Mieczysław Szalecki; Marek Tałałaj; Szabolcs Varbiro; Michał A Żmijewski
Journal:  Endokrynol Pol       Date:  2013       Impact factor: 1.582

Review 4.  Extrahepatic complications of nonalcoholic fatty liver disease.

Authors:  Matthew J Armstrong; Leon A Adams; Ali Canbay; Wing-Kin Syn
Journal:  Hepatology       Date:  2014-01-16       Impact factor: 17.425

Review 5.  Sexual dysfunction in chronic liver disease: is liver transplantation an effective cure?

Authors:  Patrizia Burra; Giacomo Germani; Annalisa Masier; Eleonora De Martin; Martina Gambato; Andrea Salonia; Patrizio Bo; Alessandro Vitale; Umberto Cillo; Francesco Paolo Russo; Marco Senzolo
Journal:  Transplantation       Date:  2010-06-27       Impact factor: 4.939

Review 6.  Primary sclerosing cholangitis, autoimmune hepatitis and overlap syndromes in inflammatory bowel disease.

Authors:  Rebecca Saich; Roger Chapman
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

7.  [Plasma leptin levels in patients with primary biliary cirrhosis and their relationship with degree of fibrosis].

Authors:  C García-Suárez; J Crespo; P Luis Fernández-Gil; J A Amado; M T García-Unzueta; F Pons Romero
Journal:  Gastroenterol Hepatol       Date:  2004-02       Impact factor: 2.102

8.  Ghrelin/Leptin-imbalance in patients with primary biliary cirrhosis.

Authors:  M Breidert; T F Zimmermann; R Schneider; G Ehninger; G Brabant
Journal:  Exp Clin Endocrinol Diabetes       Date:  2004-03       Impact factor: 2.949

9.  Polymorphism of vitamin D3 receptor and its relation to mineral bone density in perimenopausal women.

Authors:  D Boroń; A Kamiński; D Kotrych; A Bogacz; I Uzar; P M Mrozikiewicz; B Czerny
Journal:  Osteoporos Int       Date:  2014-11-19       Impact factor: 4.507

10.  Vitamin D receptor gene polymorphisms, bone mineral density and fractures in postmenopausal women with osteoporosis.

Authors:  Wanda Horst-Sikorska; Joanna Dytfeld; Anna Wawrzyniak; Michalina Marcinkowska; Michał Michalak; Edward Franek; Luiza Napiórkowska; Natalia Drwęska; Ryszard Słomski
Journal:  Mol Biol Rep       Date:  2012-10-17       Impact factor: 2.316
View more
  19 in total

1.  Association between primary biliary cholangitis and osteoporosis: meta-analysis.

Authors:  Junyu Fan; Qian Wang; Lingyun Sun
Journal:  Clin Rheumatol       Date:  2017-09-26       Impact factor: 2.980

2.  Treatment Response and Outcome with Two Different Prednisolone Regimens in Autoimmune Hepatitis.

Authors:  Tugrul Purnak; Cumali Efe; Taylan Kav; Staffan Wahlin; Ersan Ozaslan
Journal:  Dig Dis Sci       Date:  2017-09-04       Impact factor: 3.199

Review 3.  A narrative review of nutritional abnormalities, complications, and optimization in the cirrhotic patient.

Authors:  Edgewood R Warner; Fuad Z Aloor; Sanjaya K Satapathy
Journal:  Transl Gastroenterol Hepatol       Date:  2022-01-25

4.  Serum biomarker-based osteoporosis risk prediction and the systemic effects of Trifolium pratense ethanolic extract in a postmenopausal model.

Authors:  Yixian Quah; Jireh Chan Yi-Le; Na-Hye Park; Yuan Yee Lee; Eon-Bee Lee; Seung-Hee Jang; Min-Jeong Kim; Man Hee Rhee; Seung-Jin Lee; Seung-Chun Park
Journal:  Chin Med       Date:  2022-06-14       Impact factor: 4.546

5.  Reduced Serum IGF-1 Associated With Hepatic Osteodystrophy Is a Main Determinant of Low Cortical but Not Trabecular Bone Mass.

Authors:  Zhongbo Liu; Tianzhen Han; Haim Werner; Clifford J Rosen; Mitchell B Schaffler; Shoshana Yakar
Journal:  J Bone Miner Res       Date:  2017-11-06       Impact factor: 6.741

6.  Post-surgery cholecystectomy, hepatectomy, and pancreatectomy patients increase the risk of osteoporotic vertebral fracture.

Authors:  Wei-Zen Cheng; Yun-Lan Lin; Yuan-Chih Su; Mei-Chen Lin; Chang-Hsing Tseng; Ruey-Mo Lin; Sheng-Teng Huang
Journal:  J Bone Miner Metab       Date:  2020-08-05       Impact factor: 2.626

7.  Tanshinone‑IIA attenuates the deleterious effects of oxidative stress in osteoporosis through the NF‑κB signaling pathway.

Authors:  Shaowen Zhu; Wanfu Wei; Zhiwei Liu; Yang Yang; Haobo Jia
Journal:  Mol Med Rep       Date:  2018-03-14       Impact factor: 2.952

8.  Bone mineral density loss in patients with cirrhosis.

Authors:  Ibrahim N Muhsen; Omar AlFreihi; Faisal Abaalkhail; Abdullah AlKhenizan; Mohammed Khan; Abdelmoneim Eldali; Fahad Alsohaibani
Journal:  Saudi J Gastroenterol       Date:  2018 Nov-Dec       Impact factor: 2.485

9.  Suboptimal Level of Bone-Forming Cells in Advanced Cirrhosis are Associated with Hepatic Osteodystrophy.

Authors:  Chhagan Bihari; Deepika Lal; Monika Thakur; Sukriti Sukriti; Dhananjay Mathur; Anupama G Patil; Lovkesh Anand; Guresh Kumar; Shvetank Sharma; Shalini Thapar; Apurba Rajbongshi; Archana Rastogi; Anupam Kumar; Shiv K Sarin
Journal:  Hepatol Commun       Date:  2018-09-04

10.  Osteoporosis and Jaw Abnormalities in Panoramic Radiography of Chronic Liver Failure Patients.

Authors:  Janan Ghapanchi; Maryam Zahed; Abdolaziz Haghnegahdar; Niloofar Niakan; Azita Sadeghzadeh
Journal:  Biomed Res Int       Date:  2018-08-26       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.